ZanXRay
The computed 12-month bankruptcy probability of ZanXRay is 4.8% (elevated). The 2024 annual accounts show equity of €151k and a net result of €177k. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €151k |
| Net result | €177k |
| Active | 2 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €232k |
| Net profit | €177k |
| Cash flow | €178k |
| Staff costs | - |
| Income taxes | €54k |
| Dividends | €30k |
| Total assets | €240k |
| Equity | €151k |
| Debt | €89k |
| of which ≤ 1y | €89k |
| of which > 1y | - |
| Working capital | €150k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 2.68 |
| Quick ratio | 2.68 |
| Working capital ratio | 62.5% |
| Solvency | 62.7% |
| Debt / equity | 0.59 |
| Long-term debt ratio | - |
| Interest coverage | 4175.28 |
| Gross margin | - |
| Net margin | - |
| ROA | 73.8% |
| ROE | 117.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €240k |
| Fixed assets | 21/28 | €629 |
| Tangible fixed assets | 22/27 | €629 |
| Current assets | 29/58 | €239k |
| Amounts receivable within one year | 40/41 | €94k |
| Cash & bank | 54/58 | €145k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €240k |
| Equity | 10/15 | €151k |
| Contributions / capital | 10/11 | €4k |
| Accumulated profits (losses) | 14 | €147k |
| Amounts payable | 17/49 | €89k |
| Amounts payable within one year | 42/48 | €89k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €232k |
| Operating result | 9901 | €231k |
| Financial income | 75 | €93 |
| Financial charges | 65 | €55 |
| Result before taxes | 9903 | €231k |
| Income taxes | 67/77 | €54k |
| Net result for the period | 9904 | €177k |
| Result to be appropriated | 9905 | €177k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 03-01-2024 |
| Status | Active |
| Postal code | 1020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21816G0093/00L004 | Brussels | 180 m² | 1 · 74 m² | 11.7 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | ZanXRay |